Ligand validation:3SG9

KAN: KANAMYCIN A

KAN is a Ligand Of Interest in 3SG9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3SG9_KAN_A_304	5%	21%	0.234	0.643	1.61	1.69	6	11	2	0	100%	1
3SG9_KAN_B_305	1%	30%	0.378	0.573	1.37	1.4	7	7	2	0	100%	1
4DFU_KAN_A_401	39%	53%	0.172	0.877	0.66	1.16	-	7	1	0	100%	1
4DFB_KAN_B_401	24%	43%	0.164	0.794	0.74	1.46	-	8	2	0	100%	1
4QC6_KAN_A_201	99%	70%	0.042	0.979	0.44	0.71	-	-	0	0	100%	1
4FEW_KAN_F_301	96%	41%	0.067	0.974	0.88	1.39	1	5	0	0	100%	1
4GKI_KAN_I_301	96%	40%	0.068	0.975	0.9	1.42	2	7	0	0	100%	1
4FEU_KAN_B_301	94%	47%	0.076	0.975	0.74	1.3	1	6	0	0	100%	1
6O5U_KAN_A_301	92%	52%	0.079	0.971	0.59	1.24	-	6	0	0	100%	0.34

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.